Pharmacy sales in Ukraine for the January–March 2025 period rose by 11.13% in monetary terms compared to the same period in 2025—to more than 60.245 billion UAH, while in volume terms they decreased by 4.8%—to nearly 270,958 thousand packages, the company “Business Credit” reported to the agency “Interfax-Ukraine,” citing data from a study.
According to the data, the weighted average price of the pharmacy basket of goods for January–March 2026 was 222.34 UAH per package, which is 16.78% higher than during the same period a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 13.9% in monetary terms—to more than 48.426 billion UAH—and by 4.85% in volume terms compared to the same period in 2025, reaching nearly 211.947 million packages.
The weighted average retail price of medicines for the first two months of 2026 was 228.49 UAH per package, which is 8.63% higher than in January–March 2025.
At the same time, pharmacy sales of dietary supplements in the first three months of 2026 increased by 14.5% in monetary terms—to nearly 7.03 billion UAH—while sales in volume terms decreased by 14.97%, to 22.378 million packages. The weighted average price in this segment rose by 34.7%—to 314.13 UAH per unit.
As reported, pharmacy sales in Ukraine for 2025 increased by 14.23% in monetary terms compared to 2024—to more than UAH 220.287 billion, while in volume terms they decreased by 2.25%—to nearly 1.135 million packages. The weighted average price of items in the pharmacy basket at the end of 2025 was 194.68 UAH per package, which is 16.86% higher than a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 12.79% in monetary terms—to nearly UAH 170.318 billion—while in volume terms, they decreased by 0.2% compared to 2024, to 808.546 million packages.
The weighted average retail price of medicines at the end of 2025 was 210.65 UAH per package, which is 13% higher than at the end of 2024.
The pharmaceutical company “Farmak” remains the leader in retail sales in 2025 among domestic companies, with sales of nearly 10.978 billion UAH. The top 5 also included the pharmaceutical company “Darnitsa” (7.473 billion UAH), “Kyiv Vitamin Plant” (KVZ, nearly 6.842 billion UAH), ‘Arterium’ (5.975 billion UAH), and “Pharma Star/Acino” (2.9 billion UAH).
